Nasdaq
$4.87▲ 0.31%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $364.4MShares out 74.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
17- 9.21After-hours26.09.22 07:234Ownership#●●●#●●●
TELOS CORP
John B. Wood, an executive at Telos Corp, reported a change in beneficial ownership of company securities on September 21, 2026. This filing formalizes the insider's equity transaction in accordance with Form 4 requirements.…more
$4.87+0.31%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.21After-hours26.09.22 07:18144Ownership
TELOS CORP
John B. Wood of Telos Corp has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of an insider's plan to dispose of their holdings.…more
$4.87+0.31%vs prev closeView filingShare - 9.21After-hours26.09.22 06:104Ownership
TELOS CORP
Telos Corp executive Gary Mark Bendza reported a change in his beneficial ownership of company securities on September 18, 2026. This filing serves as a standard disclosure regarding the executive's stock holdings.…more
$4.87+0.31%vs prev closeView filingShare
16 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.5Regular26.10.06 04:00#●●●#●●●
Telos Secures $13.5 Million Contract for Air Force Cyber Support
Telos has been awarded a three-year, $13.5 million contract to provide cyber support and Xacta platform maintenance for U.S. Air Force intelligence systems. This agreement ensures continued security and operational readiness for mission-critical intelligence infrastructure.…more
$4.87+0.31%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.1Regular26.10.02 02:30
●●●●●●●● ●●●●● ●●●●●●
Telos Corporation has secured a 12-month contract to provide its Xacta SaaS platform to the U.S. Department of Commerce Office of Inspector General. This award highlights the continued adoption of the company's cyber governance and compliance solutions across federal agencies.…more
$4.87+0.31%vs prev close - 9.30Pre-market26.09.30 20:04
●●●●●●●● ●●●●● ●●●●●●
Tiziana Life Sciences has submitted a request for FDA Orphan Drug Designation for its drug candidate Foralumab to treat Multiple System Atrophy. While this marks a step in the development process, the impact remains neutral until further regulatory progress is made.…more
$4.87+0.31%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report